Key facts
- BrainCheck’s last known valuation is $32.4M (Jul 2024).
- It has raised $49.7M across 7 recorded rounds; the latest was Early Stage VC ($15.4M) in Dec 2023.
- Notable investors include Springboard Enterprises, Flybridge (New York), Startupbootcamp Holding, Texas Medical Center, XFactor Ventures — 23 tracked in total.
- BrainCheck has filed 8 Form Ds with the SEC since 2015, most recently Jan 2024 ($15.4M sold to 7 investors).
- Status: Privately Held (backing).
- ·Post-money valuations for all 7 rounds
- ·The complete investor list — 23 names
- ·Watchlist + deal alerts for BrainCheck
Funding rounds
7 roundsAbout BrainCheck
Developer of a health assessment and management application designed to assist individuals in making decisions about cognitive health concerns. The company's application connects patients and care teams in both the concussion and dementia markets and also offers a screening tool and interactive tests that users can access to assess brain health on any mobile device or browser and receive results on the spot, enabling clinicians to track brain health for significant changes and share results with clinicians.
- Sector
- Healthcare
- HQ
- Austin, TX, United States
- Founded
- 2015
- Employees
- 61
- Website
- braincheck.com/
- Ownership
- Privately Held (backing)
BrainCheck doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in BrainCheck shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on BrainCheck in its N-PORT filings yet. We sweep new filings monthly.